Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. - Wikidata - wikimedia - TriplyDB

Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation.

Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation.

http://www.wikidata.org/entity/Q37110768

about

Vitamin C for preventing and treating the common cold Vitamin C for preventing and treating the common cold Maternal bisphenol a exposure promotes the development of experimental asthma in mouse pups Activation of innate immune antiviral responses by Nod2 Respiratory Syncytial Virus and Cellular Stress Responses: Impact on Replication and Physiopathology Melatonin: its possible role in the management of viral infections--a brief review Critical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesis Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.Effect of NMSO3 treatment in a murine model of human metapneumovirus infection.Role of peroxiredoxin 1 and peroxiredoxin 4 in protection of respiratory syncytial virus-induced cysteinyl oxidation of nuclear cytoskeletal proteins.TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis.The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis.RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection.Role of hydrogen sulfide in paramyxovirus infections.Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.In vitro membrane stabilizing, thrombolytic and antioxidant potentials of Drynaria quercifolia L., a remedial plant of the Garo tribal people of Bangladesh.Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics Respiratory syncytial virus infection down-regulates antioxidant enzyme expression by triggering deacetylation-proteasomal degradation of Nrf2.Oxidative stress in Nipah virus-infected human small airway epithelial cells.IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus.Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus Update in critical care 2006.T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection.Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors.Induction of DNA double-strand breaks and cellular senescence by human respiratory syncytial virus.Suppression of IRG-1 Reduces Inflammatory Cell Infiltration and Lung Injury in Respiratory Syncytial Virus Infection by Reducing Production of Reactive Oxygen Species.MyD88 controls human metapneumovirus-induced pulmonary immune responses and disease pathogenesis.Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.Respiratory syncytial virus infection induces a reactive oxygen species-MSK1-phospho-Ser-276 RelA pathway required for cytokine expression.Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis.Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival Are reactive oxygen species always detrimental to pathogens?A renewed focus on the interplay between viruses and mitochondrial metabolism.Reactive oxygen and nitrogen species during viral infections.Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models.Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response.

P2860

Q24201652-61ABB740-3896-402F-8AC0-F833991CBE51 Q24244256-FF74B2D0-3849-46EE-99D7-8F5A00D6BA46 Q24633807-D015054C-8EB2-4963-B8E2-91676AAF0388 Q24646833-355CB031-49DD-466C-9C10-76C472B5F394 Q26748983-45C6D7F0-E997-4E0D-B28F-92BD091E66FA Q26825125-09CC5D7B-238C-421B-8489-B0DB93FD8DF9 Q27302959-6C4FB6FB-0A16-444C-865F-70354B95804B Q28387231-482C9F05-18CA-4213-8951-9FC612CC7A14 Q30485791-A2F24E6F-4406-4EE0-B1DB-A837D46E3C10 Q33567504-E4DE6A81-D02E-4AD4-BAEC-A1839989BFE4 Q34120066-F49E8070-C26A-4F3A-8516-5282628A17C5 Q34147516-3477985B-D9D7-45C2-A109-FF646F564EC3 Q34731547-B20AC3B9-0756-425F-B634-4B011E5A0D86 Q35107695-B734F77B-1574-461B-BDE9-3E6197B865A0 Q35187313-83B3C428-13B9-4B65-9D52-2C11B59A09B4 Q35531231-C5974F20-ABFB-4F68-B2B6-2FD97F89386A Q35641468-7C9FCF8F-6CC8-4A99-AFE2-5937F5FBA027 Q35763742-C410D3C3-8297-4597-B392-12FE9236066E Q36067896-0A0B580C-A51B-41E8-814B-E81740F0F0D6 Q36174346-3F599D38-AAB3-439E-8FD7-619EF4986F85 Q36236921-9A1FF7D8-424B-4679-8D72-61BDA6B1C7FD Q36255058-CBF23502-0C61-43C8-BD33-783B4002321E Q36389523-B32AE523-01BA-4B4B-A13E-5B6D4BC76208 Q36444085-63947B93-D4BA-4759-8C75-D2D9398AD67B Q36494613-2B19459B-2D47-49E6-A3B1-C34A993B9002 Q36769694-6588A392-41DB-47D4-8F21-20325977DE46 Q36845854-DC315348-F667-48F8-862E-3586FECD74B5 Q36887564-6BFCD4FE-648A-4056-8F5A-046506C38F19 Q36913291-4347695F-4D90-4348-BBA9-8B0827B81F6C Q37174419-C434C0EA-93C0-493E-9168-F518565213C8 Q37286394-9B018A3A-3479-4587-AD21-4BA72D479826 Q37355470-A46266AB-E6FD-4389-A6F7-70C99314495B Q37365383-0C0BCB4B-06A9-419E-893B-9D76957A049F Q37421827-CFFB93F5-B133-40E4-AE5D-5AA1F58233A8 Q37547432-B29B922E-C689-459B-9916-657D78905BBA Q37584947-81360DE8-F1F0-4AA8-8CAA-2FB8F192F520 Q38171703-2DBEC85F-30AC-49B1-B6D8-C8E73F56B453 Q38231321-D279615D-7FF1-464E-9837-AEBFFD22A474 Q38551047-32A34EEF-FB60-4192-B0FA-B3216041564D Q38751350-110B6FC9-5C0A-44E0-B7F0-5BD0871BB305

P2860

Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation.

http://www.wikidata.org/entity/Q37110768

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 September 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antioxidant treatment ameliora ...... disease and lung inflammation.

@en

Antioxidant treatment ameliora ...... disease and lung inflammation.

@nl

type

label

Antioxidant treatment ameliora ...... disease and lung inflammation.

@en

Antioxidant treatment ameliora ...... disease and lung inflammation.

@nl

prefLabel

Antioxidant treatment ameliora ...... disease and lung inflammation.

@en

Antioxidant treatment ameliora ...... disease and lung inflammation.

@nl

P1433

Q37110768-FBDABB4A-6DB0-47F8-9A7C-E75FB22AECE3

P1476

Q37110768-949BC7E8-47A3-48D9-BC76-95904D1F91B4

P2093

Q37110768-0BFDE918-E0B5-41B2-890A-1A9ED0318DCF

Q37110768-235F96C9-78E1-49A5-89B7-A138183A9731

Q37110768-6D48C4EB-A69E-4105-BAEF-293AE8E00EDB

Q37110768-83DFC729-2DC5-47D9-8719-18D1A879D464

Q37110768-8A4AC3F3-B789-4671-BFE3-20EF9EB2632D

Q37110768-C41FD208-F556-461B-A7D9-F915F41A6D72

Q37110768-D1B2ACB2-2432-4AFF-B838-F1E727CD57E4

Q37110768-E6B620B0-37DF-4BC2-9C3B-B43003C541EC

P2860

Q37110768-071533EB-E4FC-44EE-B47E-DEF164A1B7E3

Q37110768-1878F448-308B-4A88-9924-FCD4B2CB6B34

Q37110768-1E9D6D14-3959-409A-830F-E4007EADBD13

Q37110768-2866B8F2-1C91-4A9B-9A92-1CD40F2AD803

Q37110768-2A390A6A-940D-48B8-8790-E9AD92DBA07C

Q37110768-2F13C7FF-07AE-460E-A78B-301EA91CD90F

Q37110768-2F380F4C-557E-4E6B-B46C-114C71F6863B

Q37110768-355AD176-A07E-41D4-BB3C-67015AE1E7A9

Q37110768-3778A493-CCF7-4DB6-8D4A-39687FE2A221

Q37110768-3AADE5F7-3D26-4BB6-A5EF-F74D88C1B179

P304

Q37110768-00CFC6DD-A469-4B04-B21C-57179FCE91BB

P31

Q37110768-A1B90A57-D5C4-4706-BE3B-08735907F3C4

P356

Q37110768-8B2F6EA8-7C1B-4D2F-A1AE-CB8EE4848AFB

P407

Q37110768-C80239D6-157F-43F3-8F75-C171AC9CA10D

P433

Q37110768-643F238E-7094-41D4-8385-9AEB68B2079E

P478

Q37110768-7D7E2D35-79EE-479B-A4B5-BADCA755C292

P577

Q37110768-E51F699B-8CA2-4BBD-BBE8-5E3213398872

P698

Q37110768-FDE72130-AAE5-4FFD-9727-CFF9582826C0

P921

Q37110768-2C801ACA-B0D9-4B0B-9EFA-9EED5F41511B

P932

Q37110768-81D670F1-EE34-4920-93B5-8ECF8AED9E3F

P356

RCCM.200603-319OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Antioxidant treatment ameliora ...... disease and lung inflammation.

@en

P2093

Amir M Khan

http://www.w3.org/2001/XMLSchema#string

Antonella Casola

http://www.w3.org/2001/XMLSchema#string

Antonieta Guerrero-Plata

http://www.w3.org/2001/XMLSchema#string

Giovanni Suarez-Real

http://www.w3.org/2001/XMLSchema#string

Giuseppe N Colasurdo

http://www.w3.org/2001/XMLSchema#string

Patrick A Adegboyega

http://www.w3.org/2001/XMLSchema#string

Roberto P Garofalo

http://www.w3.org/2001/XMLSchema#string

Shawn Monique Castro

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperresponsiveness to inhaled but not intravenous methacholine during acute respiratory syncytial virus infection in mice

Synergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model

Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase.

Respiratory syncytial virus: A continuing culprit and conundrum.

Oxidative stress and pulmonary inflammation: pharmacological intervention with antioxidants.

Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.

Oxidative stress and gene regulation.

Redox regulatory mechanisms of cellular signal transduction.

Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections.

Immune-mediated disease pathogenesis in respiratory syncytial virus infection.

P304

1361-1369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200603-319OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17008643

http://www.w3.org/2001/XMLSchema#string

P921

P932

2648297

http://www.w3.org/2001/XMLSchema#string